Evidence map›Paper›PMID 33987687›Full record

ArticleMicrobial ecology2022

The Unexplored Wealth of Microbial Secondary Metabolites: the Sphingobacteriaceae Case Study.

Gonçalo Figueiredo, Margarida Gomes, Claúdia Covas, Sónia Mendo, Tânia Caetano

Abstract read
PubMed Publisher
In one paragraph

Article in Microbial ecology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genome-based reassessment ofCurrent research in microbial sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Inoculum of EndophyticPlants (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Complete genome sequence ofMicrobiology resource announcements · 2024
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gonçalo Figueiredo *CESAM and Department of Biology, University of Aveiro, 3810-193, Aveiro, Portugal.ORCID http://orcid.org/0000-0003-0757-187X
Margarida Gomes *CESAM and Department of Biology, University of Aveiro, 3810-193, Aveiro, Portugal.ORCID http://orcid.org/0000-0003-2018-7717
Claúdia CovasCESAM and Department of Biology, University of Aveiro, 3810-193, Aveiro, Portugal.ORCID http://orcid.org/0000-0001-7304-6278
Sónia MendoCESAM and Department of Biology, University of Aveiro, 3810-193, Aveiro, Portugal.ORCID http://orcid.org/0000-0001-5057-5660
Tânia CaetanoCESAM and Department of Biology, University of Aveiro, 3810-193, Aveiro, Portugal. tcaetano@ua.pt.ORCID http://orcid.org/0000-0001-9157-8761
University of Aveiro · PT

Funding

Fundação para a Ciência e a Tecnologia CEECIND/01463/2017Fundação para a Ciência e a Tecnologia SFRH/BD/98446/2013Fundação para a Ciência e a Tecnologia UIDP/50017/2020+UIDB/50017/2020
6 · The paper itself

Abstract

Research on secondary metabolites (SMs) has been mostly focused on Gram-positive bacteria, especially Actinobacteria. The association of genomics with robust bioinformatics tools revealed the neglected potential of Gram-negative bacteria as promising sources of new SMs. The family Sphingobacteriaceae belongs to the phylum Bacteroidetes having representatives in practically all environments including humans, rhizosphere, soils, wastewaters, among others. Some genera of this family have demonstrated great potential as plant growth promoters, bioremediators and producers of some value-added compounds such as carotenoids and antimicrobials. However, to date, Sphingobacteriaceae's SMs are still poorly characterized, and likewise, little is known about their chemistry. This study revealed that Sphingobacteriaceae pangenome encodes a total of 446 biosynthetic gene clusters (BGCs), which are distributed across 85 strains, highlighting the great potential of this bacterial family to produce SMs. Pedobacter, Mucilaginibacter and Sphingobacterium were the genera with the highest number of BGCs, especially those encoding the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs), terpenes, polyketides and nonribosomal peptides (NRPs). In Mucilaginibacter and Sphingobacterium genera, M. lappiensis ATCC BAA-1855, Mucilaginibacter sp. OK098 (both with 11 BGCs) and Sphingobacterium sp. 21 (6 BGCs) are the strains with the highest number of BGCs. Most of the BGCs found in these two genera did not have significant hits with the MIBiG database. These results strongly suggest that the bioactivities and environmental functions of these compounds, especially RiPPs, PKs and NRPs, are still unknown. Among RiPPs, two genera encoded the production of class I and class III lanthipeptides. The last are associated with LanKC proteins bearing uncommon lyase domains, whose dehydration mechanism deserves further investigation. This study translated genomics into functional information that unveils the enormous potential of environmental Gram-negative bacteria to produce metabolites with unknown chemistries, bioactivities and, more importantly, unknown ecological roles.

Indexed as

ActinobacteriaBacteroidetesComputational BiologyGenomicsHumansMultigene FamilyantiSMASHBacteroidetesBiG-SCAPEGenome miningMucilaginibacterSphingobacterium

Identifiers

PMID33987687
OpenAlexW3161313838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.